We developed a high-performance liquid chromatographytandem mass spectrometry (HPLC-MS-MS) method to measure metabolites of atrazine, phenylurea, and sulfonylurea herbicides in human urine. The metabolites measured in the method include atrazine mercapturate, desethyl atrazine, and desisopropyl atrazine as markers of atrazine exposure; dichlorophenyl urea, dich|orophenylmethyl urea, diuron, and linuron as markers of phenylurea herbicide exposure; and dimethoxypyrimidine, dimethylpyrimidine, and methoxymethyl triazine as markers for sulfonylurea herbicide exposure. The metabolites were extracted from urine by simple solid-phase extraction using a mixed-bed cartridge and were analyzed by HPLC-MS-MS. Quantification of the atrazine metabolites was achieved using isotope-dilution calibration. The remaining metabolites were quantified using similarly structured chemicals as internal standards. Extraction recoveries ranged from 88% to 104% (n = 5). Limits of detection for the entire method ranged from 0.125 to 1 ng/mL, and the average relative standard deviation of repeat measurements was about 13% (n = 30).
Introduction
Atrazine (ATZ) is an herbicide belonging to the triazine family. It is used to control annual grasses and broadleaf weeds, with 70-80 million pounds applied annually in the United States (1). Atrazine is used in agricultural, commercial and residential applications and is the second most abundantly applied pesticide in the United States (1).
ATZ can decompose in the environment into a series of dealkylated products. Human exposure can include exposure to ATZ and its degradation products. After absorption in humans and animals, ATZ readily metabolizes into a variety of dealkylated, hydroxylated, and mercapturate metabolites, with little agreement among animal and human studies (2, 3) . Although atrazine mercapturate (AM) has traditionally been measured to assess ATZ exposure in humans (4, 5) , a broader method including more metabolites can provide a more accurate assessment of exposure to ATZ and its degradates. Thus, to achieve a better picture of ATZ exposure, particularly in the general population, we want to expand the number of ATZ metabolites we measure to include the dealkylation metabolites and environmental degradates desethyl atrazine (4-amino-2-chloro-6-isopropylamino-l-3-5-triazine, DEA) and desisopropyi atrazine (4-amino-2-chloro-6-ethylamino-l,3,5-triazine, DIA).
Phenylurea herbicides are used for pre-and post-emergence control of broad-leaf weeds and grasses. They do not readily evaporate from the soil, and their herbicidal properties persist up to a year for some specific herbicides (6) . The relative stability of phenylurea herbicides in the environment allows for less frequent application, which is one reason they are popular for agriculture use.
Diuron and linuron are two of the more widely used commercial phenylurea herbicides (6) . They both metabolize in humans into 1-(3,4-dichlorophenyl)-3-methyi urea (DCPM urea), which may be demethylated to form 1-(3,4-dichlorophenyl) urea (DCP urea) (7) . In addition, diuron and linuron may be excreted in the urine unchanged (7) .
Sulfonylurea herbicides are a relatively new class of herbicides, consisting of 23 commercially produced variants. Also used for pre-and post-emergence weed control, their widespread use is due to their effectiveness at relatively low doses, crop selectivity, environmental friendliness, and relative safety for applicators (6) . They are divided into two groups based on their basic chemical structure: triazinyl and pyrimidinyl sulfonylureas.
In mammals, the triazinyl sulfonylurea herbicides metabo- lize into a common metabolite, 2-amino-4-methoxy-6-methyl-l,3,5-triazine (MMT) and the pyrimidinyl sulfonylurea herbicides metabolize into 2-amino-4,6-dimethoxypyrimidine (DMeOP) or 2-amino-4,6-dimethylpyrimidine (DMeP) (8) ; these metabolites are excreted in urine. Despite the widespread use, to our knowledge, no biomonitoring analytical method that can assess human exposure to these ureas exists.
To provide a more comprehensive assessment of ATZ exposure, we report a mass spectrometry-based method to measure the ATZ metabolites DEA, DIA, and AM (Table I) . Without the measurement of these additional metabolites, exposure to active atrazine related chemicals cannot be accurately assessed. To broaden the scope of the method for exposure assessment to herbicides, we also include measurement of some markers of exposure to phenylurea and sulfonylurea herbicides (Table I) .
Materials and Methods

Chemicals and standards
All solvents used were of analytic grade. Acetonitrile (ACN) and methanol (MeOH) were purchased from Tedia (Fairfield, OH). Glacial acetic acid (AcOH) was purchased from J.T. Baker (Phillipsburg, N J). Water was purified in-house with a Barnstead NANOpure Infinity ultrapure water purification system (Barnstead/Thermolyne, Dubuque, IA).
The following standards were purchased from ChemService (West Chester, PA): DEA, DIA, DMeP, diuron, and linuron. DCP urea, DCPM urea, and DMeOP were obtained from Dr. Ehrenstorfer GmbH (Augsburg, Germany). MMT was purchased from Absolute Standards (Hamden, CT). AM, ring-13C3-AM; dimethyl-d6-2-diethylamino-6-methyl-4 (1H)-pyrimidone
toluamide (DEET-d6); and methyl-4,5,6J3C 4-2-isopropyl-4-methyl-6-hydroxypyrimidine 03C4-IMPY) were obtained from Cambridge Isotope Laboratories (Andover, MA). Isotopically labeled ethyl-ds-DIA and isopropyl-@DEA used for isotope-dilution quantification were purchased from EQ Laboratories (Atlanta, GA). All native chemicals were > 99% pure, and all isotopically labeled standard had chemical and isotopic purities > 99%.
Spiking standard preparation
Ten different calibrant-spiking standards prepared in ACN contained all target analytes at concentrations ranging from 10 to 20,000 ng/IJL so that a 25-1~L aliquot spiked into 2 mL of urine would yield the specified concentration. Similarly, an internal standard solution (ISTD), which contained three labeled atrazine metabolite analogues and three labeled surrogate standards, was prepared at 1 ng/l~L. Twentyfive microliters of ISTD solution was added to each sample to yield a final ISTD concentration of 12.5 ng/mL urine.
Sample preparation
A 2-mL urine sample was spiked with 25 pL isotopically labeled internal standard solution and mixed. The sample was processed using OASIS HLB solid-phase extraction (SPE) cartridges (3-mL capacity, Waters, Milford, MA) to isolate the target analytes. The cartridge was conditioned with 1 mL MeOH and then equilibrated with 1 mL deionized water. The urine sample was loaded onto the cartridge. The cartridge was rinsed with i mL 5% MeOH to wash away any contaminants from the urine matrix that possibly adhered to the sorbent. Analytes were eluted from the column with 2 mL MeOH. The MeOH was evaporated to dryness in a TurboVap LV Evaporator (Zymark, Framingham, MA) set at 40~ using 10 psi of nitrogen. MeOH (350 ~L) was added into the tube and mixed to wash residues from sides of the tube. Again, the sample was taken to dryness. The residue was reconstituted in 50 IlL MeOH/ACN (3:17).
Instrumentation
Analytes were separated on a Prodigy column (5p, phenyl-3, 100 x 4.6 ram, Phenomenex, Torrance, CA). The column was connected to an Agilent 1100 high-performance liquid chromatography (HPLC) system consisting of an autosampler, a binary pump, a degasser, and a thermostattable column compartment (Agilent Technologies, Waldbronn, Germany). The HPLC system was interfaced to a Finnigan TSQ 7000 tripleAnalyte t quadrupole tandem mass spectrometer (MS-MS) with an atmospheric pressure chemical ionization (APCI) source (ThermoFinnigan, San Jose, CA).
HPLC-MS-MS conditions
The analytes were separated using a gradient elution at a constant flow rate of 1 mL/min. Initial mobile phase conditions were 95% A (water with 0.1% acetic acid) and 5% B (methanol with 0.1% acetic acid). From 0 to 8 minutes, mobile phase B was increased linearly to 95%. From 8 to 8.15 rain, the initial mobile phase conditions were restored and held for 3.85 rain to allow reequilibration of the column. The total run time was 12 rain, and the injection volume was 10 ]JL. The column compartment was set at 25~ The spray voltage was 4.0 kV, the vaporizer temperature was 450~ and the heated capillary was 250~ The sheath gas (N2) pressure was set to 50 psi, and the collision gas (Ar) pressure was set to 2 roT.
The acquisition method contained five time segments. All segments were operated in positive ion mode and used multiple reaction monitoring (MRM) to detect the quantification and confirmation ions listed in Table II . The first (0-4 rnin) and fifth (8.86-12 rain) segments did not contain any peaks of interest and were set up to detect only an improbable precursor/product ion transition (999@12 [999]), to produce an aesthetically enhanced chromatographic baseline during those periods. The other timed segments acquired data from 4.01 to 5.8 rnin, 5.81 to 7.0 rnin, and 7.01 to 8.85 rain (Figure 1 ).
Urine sample collection
For method development, validation, and quality control, urine was collected from volunteers anonymously. Our collection protocol was approved by the Centers for Disease Control and Prevention (CDC)'s Institutional Review Board and complied with all national and institutional guidelines for human research subjects.
Urine was collected from anonymous donors and stored at 4~ until approximately 1 L was obtained. The urine was tested to ensure no endogenous target analytes were present in the pool. The urine was then pooled and pressure filtered through a Polycap 75 TC filter device (0.6/.45-lJm pore size, Whatman, N J), which was attached to a stainless steel filtration tank. The pooled, filtered urine was further mixed for 5 rain at 4~ to produce a homogenous urine matrix to make blank samples, calibration standards, and quality control (QC) materials. * All analytes were detected in positive ion mode. + Abbreviations: DEA, desethyl atrazine; DIA, desisopropyl atrazine; AM, atrazine mercapturate; DCP urea, 1-(3,4-dichlorophenyl) urea; DCPM urea, 1-(3,4-dichlorophenyl)-3-methyl urea; DMeP, 2-amino-4,6-dimethylpyrimidine; MMT, 2-amino-4-methoxy-6-methyl-l,3,5-triazine; DMeOP, 2-amino-4,6-dimethoxypyrimidine; DEAMPY, dimethyl-d6-2-diethylamino-6-methyl-4(1 H)-pyrimidone; DEET, diethyl-rn-toluamide; and IMPY, 2-isopropyl-4-rnethyl-6-hydroxy pyrimidine. * Collision energies used for Q ion and labled ions shown, whereas those for C ion are shown in parentheses. w Q = quantification ion; C = confirmation ion. # Transition of DCP urea-MeOH adduct, which was the major species. ** Stable isotopically labeled compounds used as analogue internal standards for selected analytes.
Quantification
Pooled, filtered urine was used as the matrix material for calibrants. For each analytic run, 10 blank urine samples (2 mL each) were spiked with the 10 different standard solutions previously described to give calibration samples that ranged in concentration from 0.125 ng/mL to 250 ng/mL urine. Each calibrant was spiked with 25 pL ISTD before extraction. An additional 2 mL blank urine sample was also spiked with 25 pL of the labeled ISTD mixture to serve as a negative control. The blank urine and calibration standards were extracted according to the SPE described method.
Calibration plots were generated by plotting the area-ofthe-analyte/area-of-the-internal standard against the calibrant concentration. A best-fit line was generated that provided a slope and intercept from which unknown analyte concentrations could be calculated. A full calibrant set was analyzed with each analytic run.
Method Validation
Ion suppression
Possible matrix effects on ions were evaluated by performing an infusion ion suppression test (9) . Under normal method operating conditions, a standard mixture was infused into the MS via a syringe pump, which generated a fiat baseline. Concurrently, a blank urine-extract sample was injected by the HPLC into the MS. The normal acquisition method was applied.
Stability
A stability experiment was performed to assess any degradation of the analytes in solution. Vials of the standard mixture in ACN were stored at -70~ -25~ 4~ 25~ and 37~ for 36 days. Each analyte's MS signal responses after storage at the respective temperatures for 1, 2, 3, 7, 10, and 36 days were compared with their initial MS signal responses stored at -70~ at day 0.
Stability in urine was evaluated only over the course of the validation process of approximately one month. Evaluation of this parameter will continue.
Extraction recovery analysis
The recovery experiment was performed at two concentrations: 5 ng/mL and 50 ng/mL. For each concentration level, 25 pL of the appropriate native standard mixture was spiked into 5 of 10 blank urine samples, which yielded a final native standard concentration of 5 ng/mL or 50 ng/mL urine, depending upon the standard used. All samples were extracted according to the method. The five samples not spiked before extraction for each concentration were then spiked with the same amount of native standard as those spiked before extraction. All extracts for each concentration were then spiked with 25 pL of the labeled ISTD mixture. The rest of the clean up procedure was completed according to the method. To determine recovery, the samples spiked before extraction were compared to those spiked after extraction.
Characterization of linearity and limits of detection
The determination of the linear calibration range and limits of detection (LOD) for the analytes were estimated from several representative calibration plots per analyte. The calibration response was considered linear if the calibration curve met the criteria of less than 2% error about the slope and a R 2 of more than 0.998. The LOD concentration was set to be the lowest standard where the analyte could be easily detected with a signal-to-noise ratio of 3 or greater.
Quality control (QC)
Pooled, filtered urine was used to prepare QC pools at three concentration levels by fortifying with the appropriate native standard and mixing well. The low-level QC pool (QCL) was spiked at 1 ng/mL urine for all analytes; the medium-level QC pool (QCM) was spiked at 5 ng/mL, and the high-level QC pool (QCH) was spiked at 15 ng/mL. All QC materials were stored at --40~ until analyzed.
QC materials were characterized by 6 replicates on each of 5 days, 30 analyses in total, to determine the mean and relative standard deviation (RSD). The QC characterization results were used to determine the within-and between-day variation, as well as the accuracy of the method. The accuracy was defined as the mean of estimated value divided by the theoretical value.
For a given analytic run of 36 unknown samples, three QC materials were prepared along with the urine blank sample and the full set of calibration samples. The run was considered "out-of-control" if the calculated values of the QC samples violated the Westgard multirules (10).
Results and Discussion
Filtered mass chromatograms of the analytes in various types of samples are shown in Figure 1 . Clear separation of analyte by mass or time was achieved.
During development of the mass spectral procedures, we observed considerable solvent adduct formation with DCP urea. Instead of the expected ion at m/z 205, the major ion was at m/z 237, indicative of association adduct with MeOH (32 ainu), a major component of the mobile phase. Analyte-solvent adducts are commonly observed in HPLC, so this was not a surprise. The major product ion obtained from this precursor adduct species had a molecular weight ofm/z 127, which is an expected fragment of DCP urea representing chloroaniline. Thus, we chose to use the MeOH adduct of DCP as a precursor ion. DCP urea was the only analyte for which we encountered any MeOH adduct formation.
The method limits of detection and calibration curve information are shown in Table III . LODs ranged from 0.125 to 1 ng/mL, which is similar to levels reported in the literature as required to obtain measurable values in humans.
Although the term "recovery" is used often in the literature, few authors clarify their definition of the term. In the present study, we use the term "recovery" to indicate the percentage of the amount of the chemical that is recovered in the extraction process. Using the isotopically labeled analogues and structurally related surrogates, we are able to accurately quantify the values spiked into samples within a few percent of 100% (Table III) . This is often called a relative recovery. Overall, the extraction recoveries of the analytes ranged from 88% to 106% and were similar regardless of the analyte concentration ( Figure 2 ). Isotopically labeled analogues were available for only the three atrazine metabolites. To provide some reasonable recovery correction for analytes that lacked analogous labeled standards, we quantified the metabolites using structurally similar, isotopically labeled compounds that eluted close to the compound of interest. AM was used as a surrogate for DCPM urea; DEAMPY was used as a surrogate for DMeOP; I- DEET was used as a surrogate for diuron and linuron; and IMPY was used as a surrogate for DMeP and MMT (Table I) . The calibration plots were linear throughout the entire standard range (LOD to 250 ng/mL) (Table III) . A best-fit line of the data showed good correlation coefficients. Errors about the slope were less than 1%. No matrix effects were observed in the pooled urine samples tested that were used as matrix material for the calibration plots.
The precision of the method was determined from 30 replicate analyses of spiked QC materials over 5 different days (Table  IV) . RSDs ranged from about 3% to 19%. Most RSDs were at or below 13%. As would be expected but with some exceptions, the RSDs at higher concentrations were typically lower than those at concentrations near the LOD.
Furthermore, the chemicals appeared stable in both urine and solvent over the course of method development and validation.
Current throughput of the method is 36 unknown samples (48 samples including calibration standards, blanks, and QC materials) per day per laboratory analyst, with the analyst performing the entire procedure. Sample preparation requires approximately 4 h of analyst time. Mass spectral analysis time is 12 min per sample; thus samples are being analyzed on the instrument for about 11 h for one run. Final processing of the data requires about 2 h of analyst time. Factoring in a 20% downtime, the predicted yearly throughput of this method is approximately 8000 samples per laboratory analyst, which is suitable for large-scale studies.
This method provides a simple, fast, and specific tool for the analysis of several herbicides and some metabolites thereof. Sample clean-up requires only a basic SPE method and requires no pretreatment of samples (e.g., buffering, deconjugation, derivatization, or centrifugation). Inclusion of stable isotope analogues for some of the analytes and use of MS-MS analysis provides specificity and accuracy in their detection and quantification.
Our method also has several limitations. The chromatography of the first eluting peaks is not good, and the possibility for improvement is substantial. Stable isotope analogues are still not available for some of the analytes, thereby affecting the quantification of these analytes (DCP urea, diuron, linuron, DMeP, and MMT). Although the method has been tested on in-house QC material, it has not yet been applied to real-life samples.
Conclusions
A simple, fast, and sensitive method that incorporates a basic SPE clean-up procedure and a 12-min, isotope-dilution tandem MS analysis has been developed and validated to measure alternative metabolites to atrazine mercapturate as biomarkers for atrazine exposure in human urine samples. In addition, the analyses of some metabolites of phenylurea and sulfonylurea pesticides were also included in this method. Recoveries for all analytes ranged from 88% to 104%, and the LODs ranged from 0.125 to I ng/mL. The RSDs were acceptable and were usually below 13% across a wide range.
